II-VI Incorporated (IIVI) Given Consensus Rating of “Buy” by Analysts

II-VI Incorporated (NASDAQ:IIVI) has received a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $51.25.

A number of equities research analysts recently weighed in on the company. raised their price objective on II-VI from $50.00 to $56.00 and gave the company a “buy” rating in a research report on Wednesday, November 15th. Needham & Company LLC raised their price target on II-VI from $50.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, November 13th. ValuEngine downgraded II-VI from a “buy” rating to a “hold” rating in a report on Friday, December 1st. BidaskClub downgraded II-VI from a “buy” rating to a “hold” rating in a report on Saturday, December 2nd. Finally, Craig Hallum reissued a “buy” rating and issued a $58.00 price target (up previously from $50.00) on shares of II-VI in a report on Wednesday, November 1st.

Shares of II-VI (NASDAQ IIVI) opened at $43.60 on Friday. II-VI has a 12-month low of $27.25 and a 12-month high of $52.55. The firm has a market capitalization of $2,663.22, a PE ratio of 25.72 and a beta of 0.03. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.63 and a current ratio of 3.89.

II-VI (NASDAQ:IIVI) last issued its quarterly earnings data on Tuesday, October 31st. The scientific and technical instruments company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.04). II-VI had a net margin of 9.89% and a return on equity of 12.25%. The company had revenue of $261.50 million for the quarter, compared to the consensus estimate of $255.20 million. During the same period in the previous year, the business earned $0.35 EPS. II-VI’s revenue for the quarter was up 18.1% compared to the same quarter last year. equities analysts expect that II-VI will post 1.55 EPS for the current year.

In other news, VP David G. Wagner sold 6,577 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $47.63, for a total value of $313,262.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Mary Jane Raymond sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was sold at an average price of $45.00, for a total value of $45,000.00. Following the completion of the transaction, the chief financial officer now owns 53,415 shares of the company’s stock, valued at $2,403,675. The disclosure for this sale can be found here. In the last three months, insiders sold 61,712 shares of company stock valued at $2,749,046. Corporate insiders own 3.80% of the company’s stock.

Large investors have recently made changes to their positions in the company. Pinebridge Investments L.P. raised its stake in shares of II-VI by 1.9% in the second quarter. Pinebridge Investments L.P. now owns 7,237 shares of the scientific and technical instruments company’s stock worth $249,000 after purchasing an additional 137 shares during the last quarter. Piedmont Investment Advisors LLC purchased a new position in shares of II-VI in the second quarter worth about $407,000. SG Americas Securities LLC raised its stake in shares of II-VI by 329.0% in the second quarter. SG Americas Securities LLC now owns 15,112 shares of the scientific and technical instruments company’s stock worth $518,000 after purchasing an additional 11,589 shares during the last quarter. Aperio Group LLC raised its stake in shares of II-VI by 3.6% in the second quarter. Aperio Group LLC now owns 22,586 shares of the scientific and technical instruments company’s stock worth $775,000 after purchasing an additional 784 shares during the last quarter. Finally, Bridge City Capital LLC purchased a new position in shares of II-VI in the second quarter worth about $1,295,000. Hedge funds and other institutional investors own 80.54% of the company’s stock.

TRADEMARK VIOLATION WARNING: “II-VI Incorporated (IIVI) Given Consensus Rating of “Buy” by Analysts” was first published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.thestockobserver.com/2017/12/08/ii-vi-incorporated-iivi-given-consensus-rating-of-buy-by-analysts.html.

About II-VI

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Analyst Recommendations for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply